All that is Gold Does Not Glitter in Human Clinical Research: A Law-Policy Proposal to Brighten the Global 'Gold Standard' for Drug Research and Development
Michael J. Malinowski
Louisiana State University, Baton Rouge - Paul M. Hebert Law Center
Grant G. Gautreaux
affiliation not provided to SSRN
November 10, 2012
Cornell International Law Journal, Vol. 45, No. 185, 2012
This Article challenges the global science standard for putting new drugs on pharmacy shelves. The primary premise is that the “gold standard” of group experimental design is an antiquated extension of drug development's crude-science past, and is inconsistent with the precision of contemporary genetics - the science that increasingly dominates the drug development pipeline. The Article identifies law-policy options that would raise the standard for human clinical research under the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
Number of Pages in PDF File: 20Accepted Paper Series
Date posted: November 12, 2012
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo7 in 0.235 seconds